Document is current
Any future updates will be listed below
-
Authors
Yamaguchi, Toshifumi
Kawakami, Hisato https://orcid.org/0000-0002-3280-4850
Sakai, Daisuke
Kurokawa, Yukinori
Shimokawa, Toshio
Goto, Masahiro
Satoh, Taroh
-
Funding
Funding for this research was provided by:
Eli Lilly Japan
- License Information
-
More Information
Article History
Received: 13 April 2021
Accepted: 1 July 2022
First Online: 15 July 2022
Declarations
:
: This study has been approved by the Certified Review Board of Osaka International Cancer Institute (CRB5180012). Permission to conduct this study was obtained from the administrators of all participating facilities. Participants will be obtained written informed consent for participation in this study.
: Not applicable.
: This study was funded by Eli Lilly Company Limited and supported by OGSG. The study protocol has not been peer-reviewed by the funding body.The authors declare that they have no competing interests.
